In addition, the sunitinib resistance may be further supported by EMT [19] and by elevated expression of interleukin-8 [20], or by extracellular matrix metalloproteinase inducer (EMMPRIN) [21], which are both induced with sunitinib treatment, supporting tumor growth and angiogenesis activity. This evidence concerns the gene BSG and neoplasm.